The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Preparation is key to successful salary negotiation. Explore effective ways to get ready and increase your chances of a favorable outcome.
7,906 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Affirm stock has caught investors' attention as it swings between growth bets and risk concerns. This guide breaks do...
MP Materials is catching attention from large buyers of stock as it moves to boost magnet production and solidify the...
Legends captivate us, but their financial legacies teach us more. This guide turns the mystique of a modern icon into...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
A disciplined investor asks: can a modest, cash-backed bet on a distressed stock generate alpha? This article breaks ...
U.S. companies are piloting forest ‘bathing’ breaks to curb stress and improve productivity. Early results show mood ...
Oil markets jump as tensions with Iran intensify. The IEA warns the iran crisis worst energy shock may strain economi...
Global energy markets reel from an unprecedented disruption in energy supply. CEOs grappling with greatest energy sho...
Lucid Group stock down has turned a lot of eyes toward a bold question: should investors jump in now or wait? This ar...
Rivian is expanding beyond its trucks and SUVs into self-driving tech and ridesharing partnerships. This guide breaks...
Oil prices are climbing, and the ripple effects reach stocks, bonds, and your wallet. This guide explains what surgin...